|
Research Answers to NCI's Provocative Questions (R21)
RFA Number: RFA-CA-11-012
Research Answers to NCI's Provocative Questions (R01)
RFA Number: RFA-CA-11-011
2012 NIH Director's New Innovator Award Program (DP2)
RFA Number: RFA-RM-11-005
Application and Use of Transformative Emerging Technologies in Cancer Research
RFA Number: RFA-CA-10-003
Application and Use of Transformative Emerging Technologies in Cancer Research
RFA Number: RFA-CA-10-004
Innovative Technology Development for Cancer Research
RFA Number: RFA-CA-10-005
Technologies for Image-Guided Interventions (R01)
RFA Number: RFA-EB-09-002
Pre-Application Meeting: January 20, 2010
Innvovation in Molecular Imaging Probes (R01)
RFA Number: RFA-RM-09-022
Pre-Application Meeting: January 21, 2010
Centers of Cancer Nanotechnology Excellence
RFA Number: RFA-CA-09-012
Pre-Application Meeting: July 23, 2009
Letters of Intent Receipt Date: September 14, 2009
Application Receipt Date: October 14, 2009
View CCNE pre-application meeting details
Cancer Nanotechnology Platform Partnerships
RFA Number: RFA-CA-09-013
Pre-Application Meeting: July 23, 2009
Letters of Intent Receipt Date: September 14, 2009
Application Receipt Date: October 14, 2009
View Platform Partnership pre-application meeting details
The Early Detection Research Network: Biomarker Developmental Laboratories
RFA Number: RFA-CA-09-017
Application Receipt Date: October 29, 2009
|